Vasileios-Arsenios Lioutas, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 25 | 2023 | 2643 | 3.580 |
Why?
|
| Stroke | 30 | 2023 | 9963 | 2.260 |
Why?
|
| Brain Ischemia | 11 | 2020 | 3258 | 1.240 |
Why?
|
| Siderosis | 2 | 2020 | 102 | 1.210 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2023 | 855 | 1.060 |
Why?
|
| Vitamin K | 5 | 2019 | 294 | 0.920 |
Why?
|
| Neurology | 2 | 2022 | 762 | 0.890 |
Why?
|
| Anticoagulants | 6 | 2019 | 4595 | 0.870 |
Why?
|
| Headache Disorders, Primary | 1 | 2022 | 36 | 0.870 |
Why?
|
| Vasospasm, Intracranial | 2 | 2022 | 206 | 0.860 |
Why?
|
| Tissue Plasminogen Activator | 5 | 2022 | 1262 | 0.790 |
Why?
|
| Neuroprotective Agents | 2 | 2019 | 941 | 0.740 |
Why?
|
| Insulin | 7 | 2023 | 6575 | 0.710 |
Why?
|
| CADASIL | 1 | 2020 | 84 | 0.690 |
Why?
|
| Magnesium Sulfate | 1 | 2019 | 68 | 0.670 |
Why?
|
| Intracranial Hemorrhages | 3 | 2021 | 854 | 0.600 |
Why?
|
| Hyperglycemia | 2 | 2023 | 1368 | 0.590 |
Why?
|
| Hematoma | 2 | 2018 | 755 | 0.570 |
Why?
|
| Off-Label Use | 1 | 2017 | 169 | 0.550 |
Why?
|
| Ischemic Attack, Transient | 2 | 2021 | 934 | 0.540 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 1499 | 0.530 |
Why?
|
| Foramen Ovale, Patent | 1 | 2018 | 223 | 0.520 |
Why?
|
| Vertebrobasilar Insufficiency | 2 | 2014 | 114 | 0.510 |
Why?
|
| Brain Edema | 3 | 2023 | 617 | 0.470 |
Why?
|
| Hypoglycemic Agents | 5 | 2022 | 2866 | 0.460 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 632 | 0.460 |
Why?
|
| Thrombectomy | 5 | 2021 | 679 | 0.440 |
Why?
|
| Thrombolytic Therapy | 6 | 2022 | 2161 | 0.420 |
Why?
|
| Administration, Intranasal | 5 | 2022 | 446 | 0.400 |
Why?
|
| Amblyopia | 1 | 2013 | 142 | 0.380 |
Why?
|
| Data Interpretation, Statistical | 1 | 2020 | 2714 | 0.370 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 1357 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 35342 | 0.340 |
Why?
|
| Muscle Weakness | 1 | 2012 | 414 | 0.340 |
Why?
|
| Ischemia | 1 | 2017 | 1911 | 0.330 |
Why?
|
| Hypertension | 3 | 2023 | 8455 | 0.320 |
Why?
|
| Humans | 69 | 2023 | 742088 | 0.310 |
Why?
|
| Hospital Mortality | 2 | 2018 | 5310 | 0.300 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 2014 | 0.290 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 15530 | 0.290 |
Why?
|
| Tobacco Use Disorder | 1 | 2013 | 685 | 0.290 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 2566 | 0.290 |
Why?
|
| Aged, 80 and over | 16 | 2022 | 57683 | 0.290 |
Why?
|
| Aged | 30 | 2023 | 162944 | 0.280 |
Why?
|
| Retrospective Studies | 14 | 2023 | 77098 | 0.270 |
Why?
|
| Administration, Oral | 5 | 2019 | 3913 | 0.260 |
Why?
|
| Fibrinolytic Agents | 6 | 2022 | 2156 | 0.260 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5724 | 0.250 |
Why?
|
| Cohort Studies | 9 | 2023 | 40450 | 0.250 |
Why?
|
| Deferoxamine | 2 | 2022 | 151 | 0.250 |
Why?
|
| Male | 35 | 2023 | 349538 | 0.250 |
Why?
|
| Edema | 3 | 2023 | 790 | 0.250 |
Why?
|
| Female | 37 | 2023 | 379592 | 0.230 |
Why?
|
| Middle Aged | 28 | 2023 | 213127 | 0.220 |
Why?
|
| Brain | 7 | 2023 | 26343 | 0.220 |
Why?
|
| Alcoholism | 1 | 2013 | 1904 | 0.210 |
Why?
|
| Risk Assessment | 3 | 2021 | 23320 | 0.210 |
Why?
|
| Gross Domestic Product | 1 | 2022 | 76 | 0.200 |
Why?
|
| Treatment Outcome | 13 | 2023 | 62966 | 0.190 |
Why?
|
| Fibrinolysis | 1 | 2022 | 322 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 11695 | 0.190 |
Why?
|
| Prospective Studies | 11 | 2023 | 53187 | 0.180 |
Why?
|
| Hyperemia | 1 | 2021 | 224 | 0.180 |
Why?
|
| Vasoconstriction | 1 | 2022 | 596 | 0.180 |
Why?
|
| Risk Factors | 9 | 2023 | 72145 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3239 | 0.160 |
Why?
|
| Bystander Effect | 1 | 2017 | 81 | 0.150 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 485 | 0.150 |
Why?
|
| Recovery of Function | 2 | 2020 | 2924 | 0.150 |
Why?
|
| Headache | 2 | 2022 | 1219 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 7988 | 0.140 |
Why?
|
| Pituitary Apoplexy | 1 | 2016 | 30 | 0.140 |
Why?
|
| Prognosis | 7 | 2023 | 29010 | 0.140 |
Why?
|
| Deglutition Disorders | 1 | 2022 | 604 | 0.140 |
Why?
|
| Dysarthria | 1 | 2016 | 57 | 0.140 |
Why?
|
| Workload | 1 | 2022 | 849 | 0.140 |
Why?
|
| Blood Pressure | 3 | 2023 | 8541 | 0.140 |
Why?
|
| Arteries | 1 | 2021 | 1118 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2022 | 1679 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2020 | 9941 | 0.130 |
Why?
|
| Hydrocephalus | 1 | 2022 | 746 | 0.130 |
Why?
|
| Intracranial Hypotension | 1 | 2015 | 40 | 0.130 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2018 | 274 | 0.120 |
Why?
|
| Disease Progression | 3 | 2020 | 13256 | 0.120 |
Why?
|
| Incidence | 3 | 2023 | 20928 | 0.120 |
Why?
|
| Middle Cerebral Artery | 1 | 2016 | 264 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2016 | 292 | 0.120 |
Why?
|
| Internationality | 1 | 2019 | 1002 | 0.120 |
Why?
|
| Leukoencephalopathies | 1 | 2016 | 238 | 0.120 |
Why?
|
| Basilar Artery | 1 | 2014 | 200 | 0.120 |
Why?
|
| Vertebral Artery | 1 | 2014 | 192 | 0.110 |
Why?
|
| Intracranial Pressure | 1 | 2016 | 326 | 0.110 |
Why?
|
| Intracranial Hypertension | 1 | 2016 | 186 | 0.110 |
Why?
|
| Sodium Chloride | 1 | 2015 | 625 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2023 | 2304 | 0.110 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 13921 | 0.110 |
Why?
|
| Hospitalization | 3 | 2021 | 10232 | 0.110 |
Why?
|
| Magnetic Field Therapy | 1 | 2012 | 28 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2020 | 21719 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2023 | 2024 | 0.100 |
Why?
|
| Patient Transfer | 1 | 2018 | 760 | 0.100 |
Why?
|
| Glucose | 1 | 2023 | 4391 | 0.100 |
Why?
|
| Corpus Callosum | 1 | 2015 | 737 | 0.100 |
Why?
|
| Consensus | 1 | 2020 | 2935 | 0.100 |
Why?
|
| Upper Extremity | 1 | 2015 | 648 | 0.090 |
Why?
|
| Patient Admission | 1 | 2018 | 1380 | 0.090 |
Why?
|
| Pandemics | 2 | 2020 | 8328 | 0.090 |
Why?
|
| Warfarin | 1 | 2018 | 1493 | 0.090 |
Why?
|
| Memory | 1 | 2020 | 2163 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 657 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 2 | 2018 | 2732 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2736 | 0.080 |
Why?
|
| ROC Curve | 1 | 2016 | 3528 | 0.080 |
Why?
|
| Mental Health | 1 | 2022 | 2997 | 0.080 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1016 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 2016 | 1340 | 0.080 |
Why?
|
| Double-Blind Method | 4 | 2023 | 12017 | 0.080 |
Why?
|
| Adult | 9 | 2023 | 213712 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 12958 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2022 | 4229 | 0.070 |
Why?
|
| Cerebral Angiography | 1 | 2012 | 1285 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2023 | 7716 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 3336 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2749 | 0.070 |
Why?
|
| Boston | 1 | 2018 | 9305 | 0.060 |
Why?
|
| Survival Rate | 1 | 2019 | 12773 | 0.060 |
Why?
|
| Massachusetts | 1 | 2016 | 8662 | 0.060 |
Why?
|
| Drainage | 2 | 2022 | 1140 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12242 | 0.050 |
Why?
|
| Prevalence | 1 | 2019 | 15194 | 0.050 |
Why?
|
| Time Factors | 3 | 2021 | 40054 | 0.050 |
Why?
|
| Sex Factors | 1 | 2016 | 10392 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4029 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2016 | 4030 | 0.050 |
Why?
|
| Endovascular Procedures | 1 | 2014 | 1973 | 0.050 |
Why?
|
| Medical Futility | 1 | 2022 | 126 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 11690 | 0.040 |
Why?
|
| Age Factors | 1 | 2016 | 18355 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 40955 | 0.040 |
Why?
|
| Collateral Circulation | 1 | 2018 | 287 | 0.040 |
Why?
|
| Acute Disease | 2 | 2020 | 7141 | 0.040 |
Why?
|
| Water | 1 | 2023 | 1388 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 279 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2022 | 6249 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 18006 | 0.030 |
Why?
|
| Eating | 1 | 2023 | 1535 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 15108 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2015 | 303 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2020 | 1007 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 1661 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 24913 | 0.030 |
Why?
|
| Plasminogen Activators | 1 | 2014 | 209 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 56350 | 0.030 |
Why?
|
| Radial Artery | 1 | 2016 | 194 | 0.030 |
Why?
|
| Women's Health | 1 | 2023 | 2034 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2014 | 168 | 0.030 |
Why?
|
| Pyramidal Tracts | 1 | 2015 | 257 | 0.030 |
Why?
|
| Body Composition | 1 | 2023 | 2400 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2023 | 39004 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 2016 | 544 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 1265 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 1995 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2885 | 0.030 |
Why?
|
| Child | 1 | 2020 | 77478 | 0.030 |
Why?
|
| Adolescent | 1 | 2020 | 85649 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2019 | 859 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2016 | 1423 | 0.030 |
Why?
|
| Cognition | 2 | 2020 | 6722 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1780 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2023 | 9846 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1707 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2016 | 1057 | 0.020 |
Why?
|
| Fever | 1 | 2016 | 1612 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4455 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2020 | 1914 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2018 | 2572 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2857 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 1737 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2018 | 3493 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 3518 | 0.020 |
Why?
|
| Registries | 1 | 2021 | 8077 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3639 | 0.020 |
Why?
|
| United States | 2 | 2023 | 69693 | 0.010 |
Why?
|
| Research Design | 1 | 2020 | 5979 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 6974 | 0.010 |
Why?
|
| Radiography | 1 | 2014 | 7010 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 168561 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15056 | 0.010 |
Why?
|
| Pregnancy | 1 | 2023 | 29087 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2015 | 9144 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 20086 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8925 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12220 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 5019 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15494 | 0.010 |
Why?
|
| Heart Failure | 1 | 2021 | 10856 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 17400 | 0.010 |
Why?
|